Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
This study has been completed.
First Received: July 12, 2002   Last Updated: June 23, 2005   History of Changes
Sponsor: Acorda Therapeutics
Information provided by: Acorda Therapeutics
ClinicalTrials.gov Identifier: NCT00041717
  Purpose

Normally, nerve fibers carry electrical impulses through the spinal cord, providing communication between the brain and the arms and legs. In people with spinal cord injury, some fibers may be destroyed at the site of injury, while others remain connected but do not work correctly to carry electrical impulses. As a result, subjects with an incomplete spinal cord injury may have spasticity which is muscle spasms or muscle stiffness that makes movement difficult. Fampridine-SR is an experimental drug that increases the ability of the nerve to conduct electrical impulses. This study will examine the effects of Fampridine-SR on moderate to severe lower-limb spasticity, as well as the effects on bodily functions such as bladder control, bowel function and sexual function. The study will also examine the possible risks of taking Fampridine-SR.


Condition Intervention Phase
Spinal Cord Injury
Muscle Spasticity
Drug: Fampridine-SR
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Double-Blind, Placebo-Controlled, 12-Week Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Moderate to Severe Spasticity Resulting From Chronic, Incomplete Spinal Cord Injury

Resource links provided by NLM:


Further study details as provided by Acorda Therapeutics:

Estimated Enrollment: 360
Study Start Date: June 2002
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Incomplete traumatic Spinal Cord Injury (at least 18 months prior and stable for 6 months)
  • Moderate to severe lower-limb spasticity
  • Able to give informed consent and willing to comply with protocol

Exclusion Criteria:

  • Pregnancy
  • History of seizures
  • Existing or history of frequent Urinary Tract Infections
  • History of drug or alcohol abuse
  • Allergy to pyridine-containing substances
  • Received a botox injection 4 months prior to study
  • Received an investigational drug within 30 days
  • Previously treated with 4-aminopyridine (4-AP)
  • Not on stable medication dosing in 3 weeks prior to study
  • Abnormal ECG or laboratory value at screening
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00041717

  Hide Study Locations
Locations
United States, Alabama
Lakeshore Rehabilitation Hospital
Birmingham, Alabama, United States, 35209
UAB School of Medicine, 190 Spain Rehab Center
Birmingham, Alabama, United States, 35233
United States, Arizona
Barrow Neurological Institute
Phoenix, Arizona, United States, 85013
United States, Arkansas
Baptist Medical Center
Little Rock, Arkansas, United States, 72205
United States, California
Neuro-Therapeutics, Inc
Pasadena, California, United States, 91005
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304
Long Beach VA Medical Center
Long Beach, California, United States, 90822
Santa Clara Valley Medical Center
San Jose, California, United States, 95128
University of California, Davis
Sacramento, California, United States, 95817
United States, Colorado
Craig Hospital
Englewood, Colorado, United States, 80110
United States, Connecticut
Hospital for Special Care
New Britain, Connecticut, United States, 06503
United States, Delaware
Neurology Associates, P.A.
Wilmington, Delaware, United States, 19806
United States, District of Columbia
National Rehabilitation Hospital
Washington, District of Columbia, United States, 20010
United States, Florida
Miami Center to Cure Paralysis at the Univ. of Miami School of Medicine
Miami, Florida, United States, 33136
Rehabilitation Hospital
Sunrise, Florida, United States, 33351
United States, Georgia
Shepherd Spinal Center
Atlanta, Georgia, United States, 30309
United States, Illinois
Advocate Christ Medical Center-Dept. of Physical Medicine & Rehabilitation-EMG
Oak Lawn, Illinois, United States, 60453
Springfield Clinic-Neuroscience Institute
Springfield, Illinois, United States, 62702
Rehabilitation Institute of Chicago
Chicago, Illinois, United States, 60611
Hines VA Hospital
Hines, Illinois, United States, 60141
United States, Massachusetts
HEALTHSOUTH Braintree Rehabilitation Hospital
Braintree, Massachusetts, United States, 02185
HEALTHSOUTH New England Rehabilitation Hospital
Woburn, Massachusetts, United States, 01801
Boston University Medical Center
Boston, Massachusetts, United States, 02118
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States, 02114
United States, Michigan
Mary Free Bed Hospital & Rehabilitation Center
Grand Rapids, Michigan, United States, 49503
University of Michigan
Ann Arbor, Michigan, United States, 48109
Rehabilitation Institute of Michigan
Detroit, Michigan, United States, 48201
United States, Minnesota
Minneapolis VA Hospital
Minneapolis, Minnesota, United States, 55417
Mayo Clinic
Rochester, Minnesota, United States, 55905
United States, Missouri
University of Missouri
Columbia, Missouri, United States, 65212
Washington University School of Medicine, Div. of Rehab/Neurology
St. Louis, Missouri, United States, 63110
St. Louis University
St. Louis, Missouri, United States, 63104
United States, Montana
Montana Neuroscience
Missouli, Montana, United States
United States, New Jersey
Kessler Institute of Rehabilitation
West Orange, New Jersey, United States, 07052
United States, New York
SUNY Upstate Clinical Trials Office
Syracuse, New York, United States, 13045
The Burke Rehabilitation Hospital
White Plains, New York, United States, 10605
University of Rochester/Strong Memorial Hospital
Rochester, New York, United States, 14642
Helen Hayes Hospital
West Haverstraw, New York, United States, 13045
United States, North Carolina
Wake Forest University
Winston Salem, North Carolina, United States, 27157
UNC Chapel Hill
Chapel Hill, North Carolina, United States, 27599
East Carolina University
Greenville, North Carolina, United States, 27858
Coastal AHEC
Wilmington, North Carolina, United States, 28402
Charlotte Institute of Rehabilitation
Charlotte, North Carolina, United States, 28203
United States, North Dakota
Clinical Research Services
Bismarck, North Dakota, United States, 58501
United States, Ohio
Cleveland VAMC
Cleveland, Ohio, United States, 44106
Drake Center
Cincinnati, Ohio, United States, 45216
Miami Valley Hospital- Rehabilitation Institute of Medicine
Dayton, Ohio, United States, 45409
Ohio State University
Columbus, Ohio, United States, 43210
United States, Pennsylvania
Northeastern Rehabilitation Associates
Scranton, Pennsylvania, United States, 18501
Bryn Mawr Rehabilitation Hospital
Malvern, Pennsylvania, United States, 19355
HEALTHSOUTH Harmarville Rehabilitation Hospital
Pittsburgh, Pennsylvania, United States, 15238
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Good Shepherd Rehabilitation
Allentown, Pennsylvania, United States
United States, Texas
VA North Texas Health Care System
Dallas, Texas, United States, 75216
Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390
United States, Utah
Rehabilitation Services University of Utah Hospitals and Clinics
Salt Lake City, Utah, United States, 84132
United States, Virginia
Richmond VA Medical Center (Hunter Holmes McGuire)
Richmond, Virginia, United States, 23249
Hampton VA Hospital
Hampton, Virginia, United States, 23667
Medical College of Virginia/VCU
Richmond, Virginia, United States, 23298
INOVA Institute of Research and Education
Falls Church, Virginia, United States, 22042
United States, Washington
University of Washington Medical Center, Dept. of Rehabilitation
Seattle, Washington, United States, 98195
United States, West Virginia
CAMC Health Education & Research Institute
Charleston, West Virginia, United States, 25304
United States, Wisconsin
Wood VA Medical Center
Milwaukee, Wisconsin, United States, 53295
Canada, Alberta
Glenrose Rehabilitation Hospital
Edmonton, Alberta, Canada, T5G 0B7
Foothills Provincial General Hospital
Calgary, Alberta, Canada, T2N 2T9
Canada, British Columbia
G.F. Strong Rehabilitation Centre
Vancouver, British Columbia, Canada, V5Z 2G9
Canada, Manitoba
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A 1M4
Canada, New Brunswick
Stan Cassidy Centre for Rehabilitation
Fredericton, New Brunswick, Canada, E3B 4R3
Canada, Nova Scotia
QEII HSC-Nova Scotia Rehabilitation Centre
Halifax, Nova Scotia, Canada, B3M 4K4
Canada, Ontario
St. Mary's of the Lake Hospital
Kingston, Ontario, Canada, K7L 5A2
Parkwood Hospital Site, St. Joseph's Health Care
London, Ontario, Canada, N6C 5J1
Chedoke-McMaster Hospital
Hamilton, Ontario, Canada, L8N 3Z5
The Rehabilitation Centre
Ottawa, Ontario, Canada, K1H 8M2
Toronto Rehabilitation Institute, Lyndhurst Centre
Toronto, Ontario, Canada, M5G 3V9
Sponsors and Collaborators
Acorda Therapeutics
  More Information

Additional Information:
No publications provided

Study ID Numbers: SCI-F301/302
Study First Received: July 12, 2002
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00041717     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Acorda Therapeutics:
spinal cord injury
muscle spasticity

Additional relevant MeSH terms:
Neuromuscular Manifestations
Molecular Mechanisms of Pharmacological Action
Spinal Cord Diseases
Nervous System Diseases
Wounds and Injuries
Disorders of Environmental Origin
Central Nervous System Diseases
Cardiovascular Agents
Trauma, Nervous System
Pharmacologic Actions
Membrane Transport Modulators
Spinal Cord Injuries
Signs and Symptoms
Muscle Spasticity
Muscular Diseases
Musculoskeletal Diseases
Muscle Hypertonia
Therapeutic Uses
Potassium Channel Blockers
Neurologic Manifestations
4-Aminopyridine

ClinicalTrials.gov processed this record on November 27, 2009